17beta-estradiol treatment is unable to reproduce p85 alpha redistribution associated with gestational insulin resistance in rats.
Maternal metabolic adaptations are essential to ensure proper fetal development. According to changes in insulin sensitivity, pregnancy can be divided into two periods: early pregnancy, characterized by an increase in maternal insulin sensitivity, and late pregnancy, in which there is a significant increase in insulin resistance. The aims of the present work were two-fold: firstly, the molecular mechanisms associated with the development of pregnancy-related insulin resistance in peripheral tissues, mainly retroperitoneal adipose tissue and skeletal muscle, were studied in pregnant rats at 6, 11, and 16 days gestation. Secondly, the role of 17beta-estradiol in this process was elucidated in an animal model consisting of ovariectomized rats treated with 17beta-estradiol to mimic plasma gestational levels. The results support the conclusion that retroperitoneal adipose tissue plays a pivotal role in the decrease in insulin sensitivity during pregnancy, through a mechanism that involves p85 alpha redistribution to the insulin receptor and impairment of Glut4 translocation to the plasma membrane. Treatment with 17beta-estradiol did not reproduce the molecular adaptations that occur during pregnancy, suggesting that other hormonal factors presents in gestation but absent in our experimental model are responsible for p85 alpha redistribution to the insulin receptor.
Alonso
Ana
A
Physiology Area, Department of Functional Biology, University of Oviedo, Spain.
Ordóñez
Patricia
P
Fernández
Rebeca
R
Moreno
María
M
Llaneza
Plácido
P
Patterson
Angeles M
AM
González
Celestino
C
D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D016640:Diabetes, Gestational / Q000378:metabolism*; D004195:Disease Models, Animal; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D051275:Glucose Transporter Type 4 / Q000378:metabolism; D007328:Insulin / Q000097:blood; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D018482:Muscle, Skeletal / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010766:Phosphorylation; D011247:Pregnancy; D021381:Protein Transport; D051381:Rats; D017208:Rats, Wistar; D011972:Receptor, Insulin / Q000378:metabolism
D051275:Glucose Transporter Type 4; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C495694:Slc2a4 protein, rat; D004958:Estradiol; D019869:Phosphatidylinositol 3-Kinases; D011972:Receptor, Insulin